Pliant Therapeutics, Inc. (PLRX)
NASDAQ: PLRX · Real-Time Price · USD
1.450
0.00 (0.00%)
At close: Aug 22, 2025, 4:00 PM
1.480
+0.030 (2.07%)
After-hours: Aug 22, 2025, 5:51 PM EDT
Pliant Therapeutics Market Cap
Pliant Therapeutics has a market cap or net worth of $89.01 million as of August 22, 2025. Its market cap has decreased by -88.33% in one year.
Market Cap
89.01M
Enterprise Value
-113.48M
1-Year Change
-88.33%
Ranking
Category
Stock Price
$1.45
Market Cap Chart
Since June 3, 2020, Pliant Therapeutics's market cap has decreased from $737.62M to $89.01M, a decrease of -87.93%. That is a compound annual growth rate of -33.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 22, 2025 | 89.01M | -88.89% |
| Dec 31, 2024 | 801.44M | -26.12% |
| Dec 29, 2023 | 1.08B | 15.09% |
| Dec 30, 2022 | 942.52M | 93.72% |
| Dec 31, 2021 | 486.53M | -39.64% |
| Dec 31, 2020 | 806.10M | 9.28% |
| Jun 3, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 618.56B |
| Johnson & Johnson | 432.20B |
| AbbVie | 372.16B |
| UnitedHealth Group | 270.56B |
| AstraZeneca | 246.71B |
| Novartis AG | 242.21B |
| Novo Nordisk | 241.79B |
| Abbott Laboratories | 231.55B |